Stemcell
Stemcells, Inc. is poised to be among the first to market stem cell-based therapeutic products to treat diseases and disorders of the central nervous system (CNS). The Company’s proprietary HuCNS-SC® (purified human neural stem cells) platform technology is currently in clinical development for chronic spinal cord injury (SCI). Expandable and bankable, HuCNS-SC cells can ultimately be \"manufactured\" at commercial-scale as \"stem cells in a bottle,\" then distributed for patient doses, much like an off-the-shelf pharmaceutical product.
Stemcells Inc. is now Microbot Medical Inc.
Microbot Medical is a medical device company specialized in the researching, designing, developing and commercializing of transformational micro-robotics medical technologies.
Our vision is to improve the quality of life of millions of patients globally by advancing micro-robotic technologies to perform surgical procedures within the human body, and offer physicians and their patients less invasive and more precise solutions.
The company’s innovations will tap into one of the fastest growing spaces in the medical field, the minimal invasive space, while continuously delivering devices that improve an individual’s health, comfort and quality of life as well as providing added value to all other stakeholders.
本文链接： https://www.ebiomall.cn/b159-stemcellsinc/info-1552528159.html
